However, our understanding of the pathology and pathophysiology of AD, beyond the presence or absence of amyloid-β and tau, requires identification and characterization of a wide range of biological factors that drive neurodegeneration over time and different stages of disease. The gene discussed is MAPT; the disease is Alzheimer disease.